th of September. He was found to be excreting NoV on day 5 34 post-transplant and continued to excrete until day 82 post-transplant, see Table 1  6 for details of patients' samples. 7
The date of collection of the patient samples were subjected to the hospitals own 8 policy of sampling when a patient shows symptoms of diarrhoea. November and 6 th December were excluded due to batch failure), between 12 th and 13 the 22 nd of December swabs were taken more frequently to aid the infection control 14 monitoring within the unit. Sampling was performed in areas within physical 15 proximity to the children but without direct contact. In total, 116 environmental swabs 16 were collected during this period, see Table 1 for details.  17 All samples were processed for nucleic acid extraction as previously described (5). 18
Briefly, nucleic acid was extracted from faecal samples and environmental swabs 19 using a guanidinium isothiocyanate-silica method and the eluted RNA was converted 20 to cDNA using random primers and a reverse transcriptase enzyme (3). A real-time 21 PCR assay was used for the detection of NoV GI and GII strains (8) and all positives 22 were characterised using NoV S (shell) domain genotyping primers (4), and 23 genotype-specific P2 (protruding) domain primers (14), followed by nucleic acid 24 sequencing and phylogenetic analysis. 25 on July 13, 2017 by guest http://jcm.asm.org/
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NoV was detected in faecal samples collected from patients 1 (six samples) and 2 1 (five samples) during this study and the strains were genotyped on the basis of the 2 S domain as GII-3. Furthermore, 93/116 (80%) of the environmental swabs were 3 positive for NoV by real-time PCR. Of these NoV positives; 60% were characterized 4 as GII-3 strains, 6% as GII-4 and 34% were not typed due to insufficient material. 5 P2 domain typing with GII-3 specific primers was performed on all GII-3 positives, 6
however, only 18/56 (32%) of positive environmental samples for GII-3 were 7 successfully amplified and sequenced. P2 domain sequence was obtained from all 8 faecal samples. The GII-3 strains genotyped by analysis of the region encoding the S 9 domain from both patients differed only by a single silent nucleotide change in 282bp 10 of the 5'end of this region. All the environmental GII-3 strains were either patient 1-11 like or patient 2-like in this same region (Fig. 1A) . All five of the GII-4 strains 12 detected in environmental swabs were individually unique by the S domain 13 genotyping (data not shown). When analysing the P2 domain sequences, patient 1 was 14 found to be excreting three unique strains, the first strain was patient 1- Table 1 ), detected only in the 2 environmental swabs and not in the patients' faecal samples, (Fig. 1B) . 
